Willow Biopharma

Willow Biosciences is a leading synthetic biology company focused on developing and producing high-purity, plant-derived ingredients for the pharmaceutical, health and wellness, and consumer care industries. The company utilizes its proprietary FutureGrown biotechnology platform, which leverages yeast fermentation to create sustainable and cost-effective active ingredients, including functional cannabinoids and polyphenols. Willow's business model focuses on providing bio-based manufacturing solutions to partners, reducing the reliance on traditional plant extraction or chemical synthesis. By optimizing metabolic engineering and fermentation processes, the company delivers consistent, high-quality compounds with a lower environmental footprint.